HomeXBRANE • STO
add
Xbrane Biopharma AB
Previous close
kr 0.21
Day range
kr 0.21 - kr 0.22
Year range
kr 0.19 - kr 93.00
Market cap
327.98M SEK
Avg Volume
38.20M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 66.89M | 286.38% |
Operating expense | 83.77M | 19.71% |
Net income | -157.53M | -159.39% |
Net profit margin | -235.50 | 32.87% |
Earnings per share | -3.11 | -51.71% |
EBITDA | -62.25M | -28.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.40M | -66.29% |
Total assets | 653.51M | -5.36% |
Total liabilities | 482.17M | 81.52% |
Total equity | 171.34M | — |
Shares outstanding | 29.81M | — |
Price to book | 0.04 | — |
Return on assets | -25.75% | — |
Return on capital | -40.77% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -157.53M | -159.39% |
Cash from operations | -81.12M | 29.49% |
Cash from investing | -176.00K | 98.13% |
Cash from financing | -14.10M | -109.10% |
Net change in cash | -101.88M | -454.26% |
Free cash flow | -5.42M | 93.73% |
About
CEO
Founded
2008
Website
Employees
93